ARK Investment Management LLC
Position in NTLA — Intellia Therapeutics, Inc.
CIK 1697748
ST. PETERSBURG, FL
Position in NTLA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$285,536,573
+$99,528,027 QoQ
Shares Held
16,875,684
+16.3% QoQ
Ownership
12.0%
of shares outstanding
% of Portfolio
1.85%
of 13F equity value
Holder Rank
#1
of 327 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 93%
Shared 2%
None 5%
Common Shares in NTLA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ARK Investment Management LLC holds $1,628,434,493 across 17 Biotechnology names. NTLA ranks #3 (17.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRSP |
CRISPR Therapeutics AG
|
9,460,939 | $515,999,613 | |
| 2 | BEAM |
Beam Therapeutics Inc.
|
10,234,862 | $351,260,463 | |
| 3 | NTLA |
Intellia Therapeutics, Inc.
This page
|
16,875,684 | $285,536,573 | |
| 4 | RXRX |
Recursion Pharmaceuticals, Inc.
|
41,337,632 | $151,709,109 | |
| 5 | ABSI |
Absci Corp
|
12,925,271 | $149,803,890 | |
| 6 | NRIX |
Nurix Therapeutics, Inc.
|
1,793,196 | $43,502,934 | |
| 7 | PRME |
Prime Medicine, Inc.
|
8,348,746 | $30,806,872 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
300,770 | $23,848,053 |
All Filings in NTLA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $285,536,573 | 16,875,684 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $186,008,546 | 14,509,247 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $127,723,842 | 14,207,324 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $205,844,204 | 11,919,178 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $122,107,676 | 13,017,876 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $92,508,316 | 13,011,015 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $146,174,260 | 12,536,386 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $251,849,292 | 12,255,440 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $259,513,757 | 11,595,789 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $302,315,147 | 10,989,282 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $347,965,570 | 11,412,449 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $314,575,648 | 9,948,629 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $388,467,466 | 9,525,931 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $366,631,176 | 9,837,166 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $328,691,083 | 9,420,782 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $540,408,629 | 9,657,052 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $492,474,660 | 9,514,580 | Shares | Sole | 2022-07-11 | |
| 2022-03-31 | $652,651,377 | 8,981,029 | Shares | Sole | 2022-04-19 | |
| 2021-12-31 | $936,092,127 | 7,916,882 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $904,648,037 | 6,743,556 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,244,187,842 | 7,684,441 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $771,403,917 | 9,611,911 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $608,826,848 | 11,191,670 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $226,726,469 | 11,404,752 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $239,699,026 | 11,403,379 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $125,226,467 | 10,239,286 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||